Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients With Hematological Malignancies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
Blood Cancer J 2022 May 31;12(5)86, V Piechotta, SC Mellinghoff, C Hirsch, A Brinkmann, C Iannizzi, N Kreuzberger, A Adams, I Monsef, J Stemler, OA Cornely, PJ Bröckelmann, N SkoetzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.